{"schema_version":"1","generated_at":"2026-10-28T02:30:54.407Z","data_as_of":null,"url":"https://www.findmykol.com/kol/vijay-balasubramanian","json_url":"https://www.findmykol.com/kol/vijay-balasubramanian/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"vijay-balasubramanian","name":"Vijay Balasubramanian","credential":"MD","specialty":"Pulmonary Disease","specialty_raw":"Pulmonary Disease","therapeutic_area":"Respiratory","therapeutic_areas":["Respiratory"],"city":"Fresno","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1548289093","orcid":"0000-0001-7552-1992","openalex":"A5102019071"},"summary":"Vijay Balasubramanian is a Respiratory physician. OpenAlex indexes 79 publications with 520 citations (h-index 12).","overview":null,"focus":{"indications":[],"research_topics":["Respiratory"]},"scholarship":{"works_count":79,"cited_by_count":520,"h_index":12,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":25,"program_years":{"first":2021,"last":null},"rows_total":48,"shown":3,"withheld":45,"rows":[{"payer":"United Therapeutics Corporation","program_year":2025,"amount_usd":63369.22,"payment_count":84,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548289093"},{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2025,"amount_usd":54296.07,"payment_count":67,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548289093"},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":36437.75,"payment_count":40,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548289093"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1548289093","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Respiratory","share_pct":31.3,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":20.8,"drugs":[{"name":"Trelegy Ellipta","share_pct":62.3},{"name":"Breo Ellipta","share_pct":14.8},{"name":"Breztri Aerosphere","share_pct":13.6},{"name":"Fluticasone Propionate","share_pct":9.3}],"max_beneficiaries":null},{"class":"beta2-Adrenergic Agonist","setting":"prescribed","share_pct":10.5,"drugs":[{"name":"Albuterol Sulfate Hfa","share_pct":100}],"max_beneficiaries":39}]},{"area":"Cardiovascular","share_pct":15.4,"classes_total":3,"classes":[{"class":"Endothelin Receptor Antagonist","setting":"prescribed","share_pct":7.6,"drugs":[{"name":"Opsumit","share_pct":49.2},{"name":"Ambrisentan","share_pct":25.4},{"name":"Letairis","share_pct":25.4}],"max_beneficiaries":null},{"class":"Loop diuretic","setting":"prescribed","share_pct":4.9,"drugs":[{"name":"Furosemide","share_pct":100}],"max_beneficiaries":14}]},{"area":"Genitourinary & hormones","share_pct":13.2,"classes_total":1,"classes":[{"class":"Phosphodiesterase 5 Inhibitor","setting":"prescribed","share_pct":13.2,"drugs":[{"name":"Tadalafil","share_pct":78.6},{"name":"Sildenafil Citrate","share_pct":21.4}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":71.4,"facility_pct":28.6},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil","year":2023,"journal":"Pulmonary Circulation","source_url":"https://doi.org/10.1002/pul2.12255","status":"verified"},{"title":"Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil","year":2023,"journal":"Respiratory Medicine","source_url":"https://doi.org/10.1016/j.rmed.2023.107374","status":"verified"},{"title":"Barriers and facilitators to interhospital transfer of acute pulmonary embolism: An inductive qualitative analysis","year":2023,"journal":"Frontiers in Medicine","source_url":"https://doi.org/10.3389/fmed.2023.1080342","status":"verified"},{"title":"Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension","year":2023,"journal":"Advances in Therapy","source_url":"https://doi.org/10.1007/s12325-023-02711-x","status":"verified"},{"title":"Utilization of risk assessment tools in management of PAH: A PAH provider survey","year":2022,"journal":"Pulmonary Circulation","source_url":"https://doi.org/10.1002/pul2.12057","status":"verified"}],"source":"works"},"contact":{"address_1":"2335 E KASHIAN LN STE 260","city":"Fresno","state":"CA","zip":"937012234","phone":"559-256-5130","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1548289093","source":"identity"},"similar":[{"name":"Fernando Martinez","slug":"fernando-martinez","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/fernando-martinez","json_url":"https://www.findmykol.com/kol/fernando-martinez/profile.json"},{"name":"David Gozal","slug":"david-gozal","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/david-gozal","json_url":"https://www.findmykol.com/kol/david-gozal/profile.json"},{"name":"Ronald Crystal","slug":"ronald-crystal","institution":"Weill Cornell Medicine","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ronald-crystal","json_url":"https://www.findmykol.com/kol/ronald-crystal/profile.json"},{"name":"Bartolome Celli","slug":"bartolome-celli","institution":"Brigham and Women's Hospital","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/bartolome-celli","json_url":"https://www.findmykol.com/kol/bartolome-celli/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":45,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-01-14","provider_certified":"2022-08-03","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}